- Home
- AUPH vs RSI Comparison
AUPH vs RSI Comparison
Compare AUPH & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- RSI
- Stock Information
- Founded
- AUPH 1993
- RSI 2012
- Country
- AUPH Canada
- RSI United States
- Employees
- AUPH N/A
- RSI N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- RSI Services-Misc. Amusement & Recreation
- Sector
- AUPH Health Care
- RSI Consumer Discretionary
- Exchange
- AUPH Nasdaq
- RSI Nasdaq
- Market Cap
- AUPH 1.4B
- RSI 1.3B
- IPO Year
- AUPH 1999
- RSI N/A
- Fundamental
- Price
- AUPH $12.22
- RSI $21.33
- Analyst Decision
- AUPH Strong Buy
- RSI Strong Buy
- Analyst Count
- AUPH 4
- RSI 9
- Target Price
- AUPH $12.25
- RSI $18.75
- AVG Volume (30 Days)
- AUPH 1.7M
- RSI 1.5M
- Earning Date
- AUPH 11-06-2025
- RSI 10-29-2025
- Dividend Yield
- AUPH N/A
- RSI N/A
- EPS Growth
- AUPH N/A
- RSI N/A
- EPS
- AUPH 0.42
- RSI 0.26
- Revenue
- AUPH $260,111,000.00
- RSI $1,017,900,000.00
- Revenue This Year
- AUPH $16.92
- RSI $19.15
- Revenue Next Year
- AUPH $14.29
- RSI $14.26
- P/E Ratio
- AUPH $29.10
- RSI $80.66
- Revenue Growth
- AUPH 25.59
- RSI 26.99
- 52 Week Low
- AUPH $6.42
- RSI $9.22
- 52 Week High
- AUPH $12.82
- RSI $22.55
- Technical
- Relative Strength Index (RSI)
- AUPH 61.79
- RSI 62.43
- Support Level
- AUPH $11.57
- RSI $20.61
- Resistance Level
- AUPH $12.82
- RSI $21.79
- Average True Range (ATR)
- AUPH 0.36
- RSI 0.71
- MACD
- AUPH -0.10
- RSI -0.20
- Stochastic Oscillator
- AUPH 52.08
- RSI 61.25
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.